Anna Raper Daniel M Kolansky Bruce S Sachais Emma A Meagher Amanda L Baer Marina Cuchel
10.1016/j.jacl.2014.08.005
J Clin Lipidol
2015 Jan-Feb;9(1):107-12.
cyp3a4 inhibitors cholesterol homozygous familial hypercholesterolemia liver function tests lomitapide mtp inhibitor warfarin
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/25670368/
Anticholesteremic Agents / therapeutic use Benzimidazoles / therapeutic use Carrier Proteins / antagonists & inhibitors Hyperlipoproteinemia Type II / drug therapy
Anticholesteremic Agents / therapeutic use Benzimidazoles / therapeutic use Carrier Proteins / antagonists & inhibitors Hyperlipoproteinemia Type II / drug therapy Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Alanine Transaminase / blood Anticholesteremic Agents / adverse effects Anticoagulants / therapeutic use Aspartate Aminotransferases / blood Benzimidazoles / adverse effects Blood Component Removal Carrier Proteins / metabolism Cholesterol / blood Female Hematoma / diagnostic imaging Hematoma / drug therapy Hematoma / etiology Humans Liver Function Tests Magnetic Resonance Imaging Middle Aged Radiography Anticholesteremic Agents Anticoagulants BMS201038 Benzimidazoles Carrier Proteins microsomal triglyceride transfer protein Cholesterol Aspartate Aminotransferases Alanine Transaminase
PMC4563802
25670368
Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia
2015